Study of a treatment for droopy eyelid in Chinese patients
Part of Eyes & vision clinical trials.
This study tests a new treatment for Chinese patients whose droopy upper eyelid (acquired blepharoptosis) seriously affects their vision. It may help if your eyelid droops low enough to block part of your sight and you haven't had previous corrective surgery or certain eye conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have at least one eye with a droopy upper eyelid that is making it harder to see (confirmed by a special vision test, with the same result twice in one day).
- In that eye, the lid edge is very close to your eye's center (2 mm or less from the pupil).
- Your eyesight in that eye is at least 20/80 (can see the big letter on an eye chart).
- You have not had prior surgery for a droopy eyelid (except simple eyelid skin removal more than 3 months ago).
- You are not using certain eye drops or treatments (like Botox, allergy drops, or glaucoma drops) that could affect the eye or the droop.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special device that uses feedback to temporarily manage blepharoptosis, which means a droopy upper eyelid. It may help improve eyelid position without permanent surgery, but you must be able to follow the study steps.
This study checks if repeated anti-VEGF eye injections, used to treat retinal diseases, can cause the upper eyelid to droop. It follows people getting their first injection in one eye and watches for eyelid changes.
This study compares two types of stitches used during eyelid surgery to fix drooping eyelids. It aims to see which stitch keeps the eyelid height stable after surgery, which could help improve long-term results for patients.
This study tests an investigational eye drop called OT202 to see if it helps people with moderate to severe dry eye. If you join, you'll receive either the study drug or a placebo (no active ingredient) and have your symptoms and eye health monitored for several months.
This study tests a new eye drop (oxymetazoline) to see if it can help lift droopy eyelids in adults. To join, you must have a certain amount of eyelid droop and some vision loss in your upper field of view, and you should feel that the droop bothers you enough to want treatment.
This study tests two different eye drops to see if they can lift droopy upper eyelids. It may be an option for people who want a non-surgical treatment for ptosis, a condition where the eyelid droops.
Hear when a new Blepharoptosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.